New StratX Lung Analysis Platform from Pulmonx Enables Confident and Rapid Patient Selection for Zephyr® Endobronchial Valve Treatment

Posted by Jenna Widdison
On September 1, 2016

Cloud-Based Quantitative Computed Tomography (QCT) Analysis Service is Now Commercially Available

Zephyr Valves on TV – Emphysema patients in Adelaide

Posted by Chris Kellett
On June 3, 2016

A new procedure is being used to improve breathing and quality of life for patients in Adelaide

Zephyr Valves on TV – Rocker Eddie Boekelman shares his story

Posted by Chris Kellett
On June 3, 2016

"I got to the point where I just could not breathe anymore ..."

Posted by Jenna Widdison
On May 18, 2016

Redwood City, Calif. – May 18, 2016 - Pulmonx®, a leader in interventional pulmonology, today announced positive one year results from the groundbreaking STELVIO trial. The STELVIO trial is the first randomized controlled study of Zephyr® Endobronchial Valves (EBV) in severe emphysema patients...

New treatment offers hope

Posted by Chris Kellett
On April 18, 2016

It provides measurable clinical benefit for patients short of breath

Tiny valve is a breath of fresh air

Posted by Chris Kellett
On March 29, 2016

Late-stage emphysema is a type of chronic obstructive pulmonary disease (COPD). While there is no cure, treatment can help …

Patient breathing easy after procedure

Posted by Chris Kellett
On March 26, 2016

A RINGWOOD father says he has been given his life back after a revolutionary procedure helped treat his emphysema.

Posted by Jenna Widdison
On December 18, 2015

December 18, 2015, Redwood City, California - Pulmonx Corporation, a leader in interventional pulmonology, today announced that Glen French has joined the company as President, Chief Executive Officer and member of the Board of Directors. Mr. French posesses deep experience leading and transforming...

Posted by Jenna Widdison
On December 9, 2015

New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits of Medical Device for Emphysema First Prospective, Randomized Controlled Study Using the Chartis System to Select Patients Confirms Clinical Superiority of Zephyr® EBV Therapy over Medical Management in Treating Emphysema Redwood City, Calif. – December 9, 2015 – Pulmonx Corporation, a leader in interventional pulmonology,...

Posted by Jenna Widdison
On October 18, 2015

London, UK, October 28, 2015 – A clinical trial recently commenced at Royal Brompton Hospital to evaluate a minimally-invasive valve based treatment that may help patients suffering from severe emphysema breathe easier without surgery. Emphysema is a form of chronic obstructive pulmonary disease...

Posted by Jenna Widdison
On September 28, 2015

REDWOOD CITY, Calif. – September 28, 2015 - Pulmonx®, a leader in interventional pulmonology, today announced the launch of a tablet version of its Chartis Pulmonary Assessment System, a diagnostic tool designed to identify optimal patients for Zephyr® Endobronchial Valve (EBV) therapy. The Chartis...

Posted by Jenna Widdison
On September 9, 2015

September 09, 2014, Redwood City & Munich - The results of BeLieVeR-HIFi trial, the first double-blinded, randomized, controlled clinical trial to assess the impact of the Zephyr® Endobronchial Valve (EBV) for the treatment of emphysema, were presented today at the 2014 European Respiratory Society...

Posted by Jenna Widdison
On July 1, 2015

REDWOOD CITY, Calif. – July 1, 2015 –Pulmonx®, a leader in interventional pulmonology, today announced publication in The Lancet of results from the BeLieVeR-HIFi clinical trial, the first successful sham-controlled trial of any minimally invasive emphysema device. BeLieVeR-HIFi is a prospective,...

Posted by Jenna Widdison
On May 18, 2015

Denver, Colo. – May 18, 2015 –Pulmonx®, a leader in interventional pulmonology, today announced results from a retrospective analysis of the landmark VENT trial that demonstrated a statistically significant benefit in severe emphysema patients with homogeneous disease that received treatment with...

Revolutionary treatment allows patients get their breath back

Posted by Chris Kellett
On March 9, 2015

CHANNEL NINE NATIONAL NEWS A revolutionary emphysema treatment is now on offer, enabling doctors to treat patients with a non-surgical procedure that…

Posted by Jenna Widdison
On May 19, 2014

Pulmonx Products Highlighted in Multiple Presentations at ATS 2014 May 19, 2014, Redwood City, California - Pulmonx, an emerging leader in interventional pulmonology, announced today that multiple clinical abstracts examining the diagnostic and therapeutic utility of its Chartis Pulmonary...

Page 2 of 3123

New StratX Lung Analysis Platform from Pulmonx Enables Confident and Rapid Patient Selection for Zephyr® Endobronchial Valve Treatment

Zephyr Valves on TV – Emphysema patients in Adelaide

Zephyr Valves on TV – Rocker Eddie Boekelman shares his story

STELVIO Trial Shows Sustained Benefits for Emphysema Patients One Year After Treatment with Zephyr® Endobronchial Valves

New treatment offers hope

Tiny valve is a breath of fresh air

Patient breathing easy after procedure

Pulmonx Names New Chief Executive Officer

New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits of Medical Device for Emphysema

Pulmonx Starts UK Clinical Trial at Royal Brompton Hospital with Minimally Invasive Lung Valve Treatment Offering Hope to Emphysema Patients

Pulmonx Launches Chartis Tablet, Simplifying Patient Selection For Zephyr® Endobronchial Valve Therapy

Pulmonx’s Zephyr® Endobronchial Valve Demonstrates Statistically and Clinically Significant Results in a Prospective, Randomized Controlled Trial

Lancet Publication of Sham-Controlled Clinical Trial Shows Pulmonx’s Zephyr® Endobronchial Valves Deliver Significant Benefit to Emphysema Patients

Zephyr® Endobronchial Valves from Pulmonx® shown to Benefit Severe Emphysema Patients with Homogeneous Disease

Revolutionary treatment allows patients get their breath back

Pulmonx Announces First Comprehensive Report of Collateral Ventilation Assessed by the Chartis Endobronchial Catheter in Late Stage Emphysema

Pulmonx Australia Suite 5, Level 6 65 York Street Sydney, NSW 2000 Australia

1300 785 666

info@pulmonx.com.au